Wells Fargo & Company »

Bridgebio Pharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 47k 40.37
2023-09-30 $2.2M 83k 26.38
2023-06-30 $2.3M 136k 17.20
2022-12-31 $10k 1.4k 7.62
2022-09-30 $63k 6.3k 9.97
2022-06-30 $0 8.6k 0.00
2022-03-31 $359k 35k 10.16
2021-12-31 $1.3M 75k 17.05
2021-09-30 $3.1M 68k 45.83
2021-06-30 $2.5M 37k 68.18
2021-03-31 $5.5M 89k 61.60
2020-12-31 $5.2M 73k 71.21
2020-09-30 $1.5M 41k 37.50
2020-06-30 $1.5M 47k 32.61
2020-03-31 $1.1M 38k 28.99
2019-12-31 $490k 14k 35.03
2019-09-30 $282k 13k 21.48